Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Body Water | 2 | 2018 | 17 | 1.46 | Why? |
| Bronchiolitis | 3 | 2021 | 297 | 1.29 | Why? |
| Hyponatremia | 4 | 2018 | 371 | 1.29 | Why? |
| Child Welfare | 2 | 2021 | 405 | 1.15 | Why? |
| Body Composition | 2 | 2018 | 414 | 1.12 | Why? |
| Vasculitis | 2 | 2019 | 691 | 0.93 | Why? |
| Spectrum Analysis | 2 | 2018 | 112 | 0.92 | Why? |
| Potentiometry | 2 | 2017 | 11 | 0.91 | Why? |
| Mucositis | 1 | 2021 | 40 | 0.88 | Why? |
| Vasculitis, Leukocytoclastic, Cutaneous | 2 | 2019 | 88 | 0.87 | Why? |
| Mesenteric Lymphadenitis | 2 | 2017 | 16 | 0.87 | Why? |
| Infectious Mononucleosis | 2 | 2019 | 35 | 0.87 | Why? |
| Scrotum | 2 | 2017 | 48 | 0.85 | Why? |
| Myositis | 3 | 2018 | 185 | 0.80 | Why? |
| Electric Impedance | 3 | 2018 | 283 | 0.80 | Why? |
| Sodium | 3 | 2018 | 309 | 0.79 | Why? |
| Short Bowel Syndrome | 2 | 2018 | 25 | 0.76 | Why? |
| Asymptomatic Infections | 4 | 2021 | 7218 | 0.72 | Why? |
| Tongue, Fissured | 1 | 2017 | 1 | 0.72 | Why? |
| Melkersson-Rosenthal Syndrome | 1 | 2017 | 8 | 0.70 | Why? |
| Edema | 3 | 2018 | 333 | 0.70 | Why? |
| Intracellular Fluid | 1 | 2017 | 9 | 0.69 | Why? |
| Genital Diseases, Male | 1 | 2017 | 28 | 0.69 | Why? |
| Water-Electrolyte Imbalance | 1 | 2018 | 119 | 0.69 | Why? |
| Acidosis, Lactic | 1 | 2017 | 83 | 0.69 | Why? |
| Acetaminophen | 2 | 2017 | 326 | 0.68 | Why? |
| Facial Nerve | 1 | 2017 | 83 | 0.67 | Why? |
| Acid-Base Imbalance | 1 | 2017 | 46 | 0.67 | Why? |
| Electrolytes | 1 | 2017 | 103 | 0.67 | Why? |
| Pyelonephritis | 1 | 2017 | 66 | 0.65 | Why? |
| Infant, Newborn, Diseases | 2 | 2018 | 394 | 0.65 | Why? |
| Medication Errors | 1 | 2017 | 107 | 0.64 | Why? |
| Acute Pain | 1 | 2017 | 73 | 0.62 | Why? |
| Analgesics, Non-Narcotic | 1 | 2017 | 164 | 0.62 | Why? |
| Fast Foods | 1 | 2017 | 142 | 0.62 | Why? |
| Blister | 1 | 2017 | 119 | 0.60 | Why? |
| Ibuprofen | 1 | 2017 | 156 | 0.58 | Why? |
| Food Preferences | 1 | 2017 | 128 | 0.58 | Why? |
| Erythema Multiforme | 1 | 2018 | 172 | 0.58 | Why? |
| Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 213 | 0.57 | Why? |
| Ascorbic Acid | 1 | 2021 | 676 | 0.56 | Why? |
| Lactic Acid | 1 | 2017 | 393 | 0.55 | Why? |
| Nutritional Status | 2 | 2021 | 1403 | 0.51 | Why? |
| Epstein-Barr Virus Infections | 1 | 2017 | 366 | 0.49 | Why? |
| Vitamins | 1 | 2021 | 1208 | 0.46 | Why? |
| Child | 27 | 2021 | 70012 | 0.45 | Why? |
| Disasters | 1 | 2020 | 760 | 0.45 | Why? |
| Pediatric Obesity | 1 | 2017 | 492 | 0.44 | Why? |
| Renal Veins | 1 | 2010 | 13 | 0.44 | Why? |
| Ventricular Dysfunction, Right | 1 | 2018 | 639 | 0.44 | Why? |
| Venous Insufficiency | 1 | 2010 | 22 | 0.43 | Why? |
| Child Health | 1 | 2020 | 940 | 0.43 | Why? |
| Renal Dialysis | 2 | 2018 | 4358 | 0.42 | Why? |
| Infant | 17 | 2021 | 30274 | 0.39 | Why? |
| Carrier State | 1 | 2021 | 2100 | 0.38 | Why? |
| Child, Preschool | 17 | 2021 | 36283 | 0.37 | Why? |
| Skin | 2 | 2017 | 2096 | 0.36 | Why? |
| Community-Acquired Infections | 2 | 2017 | 2328 | 0.35 | Why? |
| Feeding Behavior | 2 | 2017 | 1909 | 0.34 | Why? |
| Proteinuria | 1 | 2010 | 474 | 0.32 | Why? |
| Italy | 11 | 2021 | 38444 | 0.32 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2017 | 1380 | 0.31 | Why? |
| Vitamin D | 1 | 2021 | 2904 | 0.29 | Why? |
| Acute Disease | 8 | 2019 | 6029 | 0.29 | Why? |
| Respiratory Tract Infections | 4 | 2021 | 6817 | 0.29 | Why? |
| Herpesvirus 4, Human | 2 | 2019 | 387 | 0.28 | Why? |
| Adolescent | 17 | 2021 | 86841 | 0.28 | Why? |
| Syndrome | 2 | 2021 | 1310 | 0.27 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.27 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.27 | Why? |
| Kidney Diseases | 2 | 2017 | 1434 | 0.27 | Why? |
| Renal Insufficiency, Chronic | 1 | 2018 | 2654 | 0.26 | Why? |
| Emergency Service, Hospital | 4 | 2021 | 14232 | 0.26 | Why? |
| Female | 33 | 2021 | 380317 | 0.25 | Why? |
| Male | 33 | 2021 | 367725 | 0.25 | Why? |
| Health Policy | 2 | 2020 | 6242 | 0.24 | Why? |
| Humans | 53 | 2021 | 930598 | 0.24 | Why? |
| Urinary Tract Infections | 2 | 2018 | 534 | 0.24 | Why? |
| Drug Administration Routes | 1 | 2021 | 106 | 0.22 | Why? |
| Infant Nutritional Physiological Phenomena | 2 | 2018 | 75 | 0.22 | Why? |
| Skin Diseases | 1 | 2017 | 2509 | 0.21 | Why? |
| Chlamydophila pneumoniae | 1 | 2021 | 98 | 0.21 | Why? |
| Serous Membrane | 1 | 2019 | 3 | 0.21 | Why? |
| Serositis | 1 | 2019 | 5 | 0.21 | Why? |
| Pyuria | 1 | 2019 | 3 | 0.20 | Why? |
| Shiga-Toxigenic Escherichia coli | 1 | 2018 | 7 | 0.20 | Why? |
| Dapsone | 1 | 2019 | 59 | 0.20 | Why? |
| Deuterium | 1 | 2018 | 21 | 0.20 | Why? |
| Mycoplasma pneumoniae | 1 | 2021 | 233 | 0.19 | Why? |
| Nephritis | 1 | 2019 | 39 | 0.19 | Why? |
| Hemolytic-Uremic Syndrome | 1 | 2018 | 22 | 0.19 | Why? |
| Immunoglobulin A | 3 | 2021 | 3567 | 0.19 | Why? |
| Milk, Human | 2 | 2018 | 956 | 0.19 | Why? |
| Hyperammonemia | 1 | 2017 | 10 | 0.18 | Why? |
| Acidosis, Renal Tubular | 1 | 2017 | 7 | 0.18 | Why? |
| Practice Patterns, Physicians' | 1 | 2017 | 4927 | 0.18 | Why? |
| Administration, Rectal | 1 | 2017 | 17 | 0.18 | Why? |
| Enterocolitis, Necrotizing | 1 | 2018 | 71 | 0.18 | Why? |
| Bicarbonates | 1 | 2017 | 33 | 0.18 | Why? |
| Coxsackievirus Infections | 1 | 2018 | 71 | 0.17 | Why? |
| Infant Formula | 1 | 2018 | 64 | 0.17 | Why? |
| Dietary Fats | 1 | 2018 | 96 | 0.17 | Why? |
| Drinking | 1 | 2017 | 69 | 0.17 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.17 | Why? |
| Seizures, Febrile | 1 | 2017 | 59 | 0.17 | Why? |
| Heart Block | 1 | 2017 | 59 | 0.17 | Why? |
| Fatty Acids, Unsaturated | 1 | 2017 | 70 | 0.17 | Why? |
| Parity | 1 | 2017 | 122 | 0.17 | Why? |
| Kidney | 2 | 2017 | 3648 | 0.17 | Why? |
| Causality | 1 | 2021 | 857 | 0.16 | Why? |
| Capillary Leak Syndrome | 1 | 2018 | 119 | 0.16 | Why? |
| Acute Kidney Injury | 1 | 2017 | 5762 | 0.16 | Why? |
| Nephritis, Interstitial | 1 | 2017 | 83 | 0.16 | Why? |
| Skin Diseases, Vascular | 1 | 2017 | 69 | 0.16 | Why? |
| Snacks | 1 | 2017 | 231 | 0.15 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.15 | Why? |
| Tomography | 1 | 2017 | 183 | 0.15 | Why? |
| Drug Dosage Calculations | 1 | 2017 | 243 | 0.15 | Why? |
| Blood Vessels | 1 | 2017 | 228 | 0.15 | Why? |
| Pulmonary Ventilation | 1 | 2017 | 152 | 0.15 | Why? |
| Creatine Kinase | 1 | 2017 | 386 | 0.15 | Why? |
| Cross-Sectional Studies | 5 | 2021 | 53120 | 0.15 | Why? |
| Escherichia coli Infections | 1 | 2018 | 348 | 0.14 | Why? |
| Child Health Services | 1 | 2021 | 520 | 0.14 | Why? |
| Reproducibility of Results | 3 | 2020 | 11304 | 0.13 | Why? |
| Electroencephalography | 2 | 2017 | 1242 | 0.13 | Why? |
| Hydrogen-Ion Concentration | 1 | 2017 | 993 | 0.13 | Why? |
| Abdomen | 1 | 2017 | 424 | 0.13 | Why? |
| Diagnosis, Differential | 2 | 2018 | 7220 | 0.13 | Why? |
| Facial Paralysis | 1 | 2017 | 231 | 0.13 | Why? |
| Rotavirus Infections | 1 | 2017 | 355 | 0.13 | Why? |
| Stress, Physiological | 1 | 2017 | 378 | 0.13 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.13 | Why? |
| Administration, Intravenous | 1 | 2017 | 1115 | 0.13 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.13 | Why? |
| Switzerland | 1 | 2021 | 2738 | 0.12 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.12 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.12 | Why? |
| Nasal Mucosa | 1 | 2020 | 1218 | 0.12 | Why? |
| Adult | 10 | 2021 | 244371 | 0.12 | Why? |
| Gastroenteritis | 1 | 2017 | 489 | 0.12 | Why? |
| Body Weight | 1 | 2018 | 1074 | 0.12 | Why? |
| Cities | 2 | 2021 | 4937 | 0.11 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.11 | Why? |
| Dietary Supplements | 2 | 2021 | 2251 | 0.11 | Why? |
| Antioxidants | 1 | 2021 | 1593 | 0.11 | Why? |
| Muscle, Skeletal | 1 | 2018 | 915 | 0.11 | Why? |
| Steroids | 1 | 2017 | 904 | 0.11 | Why? |
| Carbon Dioxide | 1 | 2017 | 917 | 0.10 | Why? |
| Recurrence | 2 | 2017 | 3675 | 0.10 | Why? |
| Lymph Nodes | 1 | 2017 | 1060 | 0.10 | Why? |
| Prognosis | 6 | 2018 | 32490 | 0.10 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.10 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.10 | Why? |
| Constriction, Pathologic | 1 | 2010 | 212 | 0.10 | Why? |
| Policy Making | 1 | 2017 | 829 | 0.10 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.10 | Why? |
| Prospective Studies | 4 | 2017 | 43301 | 0.10 | Why? |
| Pneumonia, Viral | 4 | 2021 | 243684 | 0.09 | Why? |
| Posture | 1 | 2010 | 199 | 0.09 | Why? |
| Coronavirus Infections | 4 | 2021 | 253789 | 0.09 | Why? |
| Seizures | 1 | 2017 | 1163 | 0.09 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2018 | 1234 | 0.09 | Why? |
| Infant, Newborn | 6 | 2020 | 23105 | 0.09 | Why? |
| Life Style | 1 | 2021 | 2708 | 0.09 | Why? |
| Body Mass Index | 1 | 2021 | 4306 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.09 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.09 | Why? |
| Vitamin D Deficiency | 1 | 2021 | 1782 | 0.08 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.08 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.08 | Why? |
| Prevalence | 3 | 2017 | 25773 | 0.08 | Why? |
| Appendicitis | 1 | 2017 | 946 | 0.08 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 1454 | 0.08 | Why? |
| Leukocyte Count | 1 | 2017 | 3178 | 0.08 | Why? |
| Autoantibodies | 1 | 2017 | 2094 | 0.08 | Why? |
| Ambulatory Care Facilities | 1 | 2017 | 2063 | 0.08 | Why? |
| Aged | 7 | 2021 | 215776 | 0.08 | Why? |
| Particulate Matter | 1 | 2018 | 3249 | 0.07 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.07 | Why? |
| Risk | 1 | 2017 | 5288 | 0.07 | Why? |
| Bacterial Infections | 1 | 2019 | 2229 | 0.07 | Why? |
| Schools | 1 | 2021 | 4187 | 0.07 | Why? |
| Follow-Up Studies | 2 | 2020 | 17020 | 0.07 | Why? |
| Fatty Acids, Omega-3 | 2 | 2018 | 306 | 0.07 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.06 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.06 | Why? |
| Liver | 1 | 2017 | 4007 | 0.06 | Why? |
| Infant, Premature | 2 | 2018 | 883 | 0.06 | Why? |
| Disease Management | 1 | 2020 | 6841 | 0.06 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.06 | Why? |
| Saliva | 1 | 2018 | 4679 | 0.06 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.06 | Why? |
| Clinical Trials as Topic | 1 | 2021 | 7330 | 0.06 | Why? |
| Surgical Procedures, Operative | 1 | 2017 | 2662 | 0.05 | Why? |
| Exercise | 1 | 2021 | 6771 | 0.05 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.05 | Why? |
| Ultrasonography | 1 | 2017 | 4409 | 0.05 | Why? |
| C-Reactive Protein | 1 | 2017 | 7972 | 0.05 | Why? |
| Fever | 1 | 2017 | 7795 | 0.05 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.05 | Why? |
| Air Pollution | 1 | 2018 | 3504 | 0.05 | Why? |
| Quality of Life | 1 | 2020 | 9820 | 0.05 | Why? |
| Trans Fatty Acids | 1 | 2018 | 7 | 0.05 | Why? |
| Fatty Acids, Monounsaturated | 1 | 2018 | 42 | 0.05 | Why? |
| Fatty Acids, Omega-6 | 1 | 2017 | 43 | 0.05 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.05 | Why? |
| Urinary Tract | 1 | 2017 | 77 | 0.04 | Why? |
| Enterovirus B, Human | 1 | 2018 | 124 | 0.04 | Why? |
| Pneumonia | 1 | 2017 | 5652 | 0.04 | Why? |
| Eicosapentaenoic Acid | 1 | 2017 | 106 | 0.04 | Why? |
| Heart Failure | 1 | 2018 | 6638 | 0.04 | Why? |
| Leg | 1 | 2018 | 142 | 0.04 | Why? |
| Fatty Acids | 1 | 2018 | 238 | 0.04 | Why? |
| Nutritional Requirements | 1 | 2017 | 115 | 0.04 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.04 | Why? |
| Milk Banks | 1 | 2018 | 99 | 0.04 | Why? |
| Docosahexaenoic Acids | 1 | 2017 | 145 | 0.04 | Why? |
| Parenteral Nutrition | 1 | 2017 | 184 | 0.04 | Why? |
| Triglycerides | 1 | 2018 | 478 | 0.04 | Why? |
| Diet | 2 | 2018 | 2052 | 0.04 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.04 | Why? |
| Enteral Nutrition | 1 | 2017 | 320 | 0.03 | Why? |
| Randomized Controlled Trials as Topic | 3 | 2018 | 10649 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.03 | Why? |
| Mental Health | 1 | 2020 | 15770 | 0.03 | Why? |
| Critical Illness | 1 | 2017 | 17281 | 0.03 | Why? |
| Micronutrients | 1 | 2017 | 310 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.03 | Why? |
| Energy Metabolism | 1 | 2017 | 451 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.03 | Why? |
| Gestational Age | 1 | 2018 | 1488 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2017 | 1262 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Linear Models | 1 | 2017 | 1914 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2017 | 1755 | 0.03 | Why? |
| Radiography | 1 | 2017 | 1576 | 0.02 | Why? |
| Exanthema | 1 | 2017 | 1097 | 0.02 | Why? |
| Cystic Fibrosis | 1 | 2017 | 1104 | 0.02 | Why? |
| Hyperglycemia | 1 | 2017 | 1363 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2017 | 1956 | 0.02 | Why? |
| Patient Admission | 1 | 2021 | 5250 | 0.02 | Why? |
| Health Promotion | 1 | 2017 | 2020 | 0.02 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.02 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.02 | Why? |
| Brain | 1 | 2017 | 5133 | 0.01 | Why? |
| Anti-Inflammatory Agents | 1 | 2018 | 6153 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.01 | Why? |
Milani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(254)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(103)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_